Pancreatic cancer is one of the deadliest forms of cancer. So any bit of progress on the pancreatic cancer front is a big deal. And researchers are happy to report they've found a chemotherapy drug that can help patients who have received surgery prevent a return of the disease for a longer period of time.In a German study, participants who received Gemzar, or gemcitabine, lived an average of 13.4 months without their cancers coming back. Participants who did not receive the drug lived without the disease for 6.9 months. While the findings of this study may seem modest, they really are quite encouraging because pancreatic cancer is such a rapid killer, and patients with this disease have the worst chances of recovery.
This study, published in Wednesday's Journal of the American Medical Association, brings hope for the mere 20 percent of pancreatic cancer patients who are candidates for surgery. While surgery is the best hope for a cure, the disease still returns in the majority of cases -- so Gemzar is surely worth a shot.
It should be noted that some study authors report financial ties to Gemzar drugmaker Eli Lilly and Co. Researchers, however, report the firm had no influence in design or data interpretation.


The
The new
I will be a cancer survivor for the rest of my life. I don't think my modeling career will have that kind of longevity, though. I gave it a try -- I am not sure how I was convinced to participate as a model in a fashion show when my personality is so not conducive to strutting on a runway -- and I think I will retire after my short stint in the spotlight. The spotlight was my biggest problem really. When I walked out on stage -- two times -- I was blinded by bright lights shining in my eyes and was somewhat paralyzed by the total darkness I saw in the audience of about 700 people who came to watch me and 84 other cancer survivors this past March in the Cure by Design fashion show, sponsored by my local American Cancer Society office. I heard clapping and shouting and cheering but could not see anything in front of me. I had no sense of where my family members sat in the crowd and felt disoriented and confused. It didn't help that I had to follow arrows that were taped on the stage -- reminders of the path I had to travel on stage -- and had to wave and smile and look relaxed. Relaxed I was not -- and I am sure it was obvious to those whose faces I never could see. 







